In the coming years the possibility of having access to a patient's whole genome in the context of clinical care is becoming a real possibility. Recent discoveries in human genetics have begun to suggest that this data might have the potential to influence clinical management in the appropriate setting. Here we will discuss how personal genetic data might play an important role in the care of early rheumatic disease. We will also discuss how human genetic findings might influence the production of novel predictive biomarkers that might play an important role in the care of rheumatic diseases.
Disclosure of Interest None declared